Whitehawk Therapeutics, Inc. Cash Flow Reinvestment Rate
Latest as of March 2021:
0.00x
Whitehawk Therapeutics, Inc. cash flow reinvestment rate. Whitehawk Therapeutics, Inc. (WHWK) has a Cash Flow Reinvestment Rate of 0.00x as of March 2021, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $10.56 Million. Explore Whitehawk Therapeutics, Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$10.56 Million
USD
Capital Expenditures
$0.00
USD
Whitehawk Therapeutics, Inc. Cash Flow Reinvestment Rate by Year (None–None)
Whitehawk Therapeutics, Inc. cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Whitehawk Therapeutics, Inc.. For the full cash flow conversion analysis, see Whitehawk Therapeutics, Inc. cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow